Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14958505Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$5.7M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#918
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Gary Fanger as a PI. Multi-PI records show the full award amount for context.
- 5R44DK137649-02R44R-5280, A Novel Modified Superior Resistant Starch Therapy for Type 1 Diabetes$995.9Kaward amount
- 4R44AG084484-02R44A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis$987.2Kaward amount
- 5R44AI174332-02R44A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)$984.4Kaward amount
- 4R44AI174844-02R44A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis$956Kaward amount
- 5R44DK133061-03R44A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis$914.7Kaward amount
- 1SB1DK141356-01SB1A Novel Synthetically Engineered Oral Immunotherapy for Treating Ulcerative Colitis$673.4Kaward amount
- 5R44CA261509-04R44A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy$171.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing Gary Fanger as a PI.
FY2024 award administered by Rise Therapeutics, LLC (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardRise Therapeutics, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #918
- 2024Entered Top 25% NationallyRanked #918
- 2024Entered Top 10% NationallyRanked #918
- 2024Entered Top 5% NationallyRanked #918
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Gary Fanger.